Retinal ganglion cell protection by 17-β-estradiol in a mouse model of inherited glaucoma

Developmental Neurobiology

Volumn 67, Issue 5, 2007, Pages 603-616

  Zhou, Xiaohong ^a   Li, Feng ^a   Ge, Jian ^b   Sarkisian Jr , Steven R ^a   Tomita, Hiroshi ^c   Zaharia, Alexander ^a   Chodosh, James ^a   Cao, Wei ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

DBA 2J mouse; Estrogen; Glaucoma; Interleukin 18; Intraocular pressure; Neuroprotection; Retinal ganglion cell; Thioredoxin 1

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18 BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TAMOXIFEN; THIOREDOXIN; ANTIESTROGEN; CASPASE 3; DIGOXIGENIN; INTERLEUKIN 18; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLINDNESS; CELL LOSS; CELL SURVIVAL; CONGENITAL GLAUCOMA; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MOUSE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA GANGLION CELL; ANIMAL; BIOSYNTHESIS; DBA MOUSE; DRUG EFFECT; DRUG IMPLANT; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENETICS; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; METABOLISM; NICK END LABELING; OVARIECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CASPASE 3; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIGOXIGENIN; DRUG IMPLANTS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GLAUCOMA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-18; INTRAOCULAR PRESSURE; MICE; MICE, INBRED DBA; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE FIBERS; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; OVARIECTOMY; PHOSPHORYLATION; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN; THIOREDOXIN; UP-REGULATION;

EID: 34249846370     PISSN: 19328451     EISSN: 1932846X     Source Type: Journal    
DOI: 10.1002/dneu.20373     Document Type: Article

References (70)

1. Armaly MF. 1967. Age and sex correction of applanation pressure. Arch Ophthalmol 78:480-484.
2. Bai J, Nakamura H, Kwon YW, Hattori I, Yamaguchi Y, Kim YC, Kondo N, et al. 2003. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J Neurosci 23:503-509.
3. Bankes JL, Perkins ES, Tsolakis S, Wright JE. 1968. Bedford glaucoma survey. Br Med J 1:791-796.
4. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. 2004. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 11:69-77.
5. Bautista RD. 1999. Glaucomatous neurodegeneration and the concept of neuroprotection. Int Ophthalmol Clin 39: 57-70.
6. Behl C, Manthey D. 2000. Neuroprotective activities of estrogen: An update. J Neurocytol 29:351-358.
7. Brunet A, Datta SR, Greenberg ME. 2001. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305.
8. Buggage RR, Matteson DM, Shen DF, Sun B, Tuaillon N, Chan CC. 2003. Effect of sex hormones on experimental autoimmune uveoretinitis (EAU). Immunol Invest 32: 259-273.
9. Cambiasso MJ, Carrer HF. 2001. Nongenomic mechanism mediates estradiol stimulation of axon growth in male rat hypothalamic neurons in vitro. J Neurosci Res 66:475-481.
10. Cao W, Chen W, Elias R, McGinnis JF. 2000. Recovering negative photoreceptor cells. J Neurosci Res 60:195-201.
11. Cao W, Rajala RV, Li F, Anderson RE, Wei N, Soliman CE, McGinnis JF. 2003. Neuroprotective effect of estrogen upon retinal neurons in vitro. Adv Exp Med Biol 533:395-402.
12. Cao W, Tombran-Tink J, Chen W, Mrazek D, Elias R, McGinnis JF. 1999. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 57:789-800.
13. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. 2001. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 42:1646-1652.
14. Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE, Mummidi S. 2004. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J Biol Chem 279:20221-20233.
15. Creagh EM, Conroy H, Martin SJ. 2003. Caspase-activation pathways in apoptosis and immunity. Immunol Rev 193:10-21.
16. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: A play in three Akts. Genes Dev 13:2905-2927.
17. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. 1998. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258.
18. Dubal DB, Wise PM. 2001. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 142: 43-48.
19. Garcia-Segura LM, Azcoitia I, DonCarlos LL. 2001. Neuroprotection by estradiol. Prog Neurobiol 63:29-60.
20. Gracie JA. 2004. Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 136:402-404.
21. Gracie JA, Robertson SE, McInnes IB. 2003. Interleukin-18. J Leukoc Biol 73:213-224.
22. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: Potential mechanisms of action. Int J Dev Neurosci 18:347-358.
23. Herlaar E, Brown Z. 1999. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 5:439-447.
24. Huang WX, Huang P, Hillert J. 2004. Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis. Mult Scler 10:482-487.
25. Hue J, Kim A, Song H, Choi I, Park H, Kim T, Lee WJ, et al. 2005. IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity. Immunol Lett 96:211-217.
26. Hulsman CA, Westendorp IC, Ramrattan RS, Wolfs RC, Witteman JC, Vingerling JR, Hofman A, et al. 2001. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 154:138-144.
27. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, et al. 1998. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39:951-962.
28. Kalina U, Kauschat D, Koyama N, Nuernberger H, Ballas K, Koschmieder S, Bug G, et al. 2000. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-γ production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21. J Immunol 165:1307-1313.
29. Kaushik S, Pandav SS, Ram J. 2003. Neuroprotection in glaucoma. J Postgrad Med 49:90-95.
30. Kelly MJ, Wagner EJ. 1999. Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metab 10:369-374.
31. Kimura-Shimmyo A, Kashiwamura S, Ueda H, Ikeda T, Kanno S, Akira S, Nakanishi K, et al. 2002. Cytokine-induced injury of the lacrimal and salivary glands. J Immunother 25 (Suppl 1):S42-S51.
32. Kobayashi K, Kobayashi H, Ueda M, Honda Y. 1998. Estrogen receptor expression in bovine and rat retinas. Invest Ophthalmol Vis Sci 39:2105-2110.
33. Kong L, Li F, Soleman CE, Li S, Elias RV, Zhou X, Lewis DA, et al. 2006. Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis 21:468-477.
34. Kumar DM, Perez E, Cai ZY, Aoun P, Brun-Zinkernagel AM, Covey DF, Simpkins JW, et al. 2005. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radic Biol Med 38:1152-1163.
35. Lee AJ, Mitchell P, Rochtchina E, Healey PR. 2003. Female reproductive factors and open angle glaucoma: The Blue Mountains Eye Study. Br J Ophthalmol 87:1324-1328.
36. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello CA. 2004. Differences in signaling pathways by IL-1β and IL-18. Proc Natl Acad Sci USA 101:8815-8820.
37. Lee SJ, McEwen BS. 2001. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591.
38. Leske MC. 1983. The epidemiology of open-angle glaucoma: A review. Am J Epidemiol 118:166-191.
39. Leske MC, Connell AM, Schachat AP, Hyman L. 1994. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 112:821-829.
40. Levin LA. 2003. Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol 48 (Suppl 1):S21-S24.
41. Li C, Tang Y, Li F, Turner S, Li K, Zhou X, Centola M, et al. 2006. 17β-estradiol (βE2) protects human retinal Muller cell against oxidative stress in vitro: Evaluation of its effects on gene expression by cDNA microarray. Glia 53:392-400.
42. Lorenzo A, Diaz H, Carrer H, Caceres A. 1992. Amygdala neurons in vitro: Neurite growth and effects of estradiol. J Neurosci Res 33:418-435.
43. Mahmoud RA, el-Ezz SA, Hegazy AS. 2004. Increased serum levels of interleukin-18 in patients with diabetic ne phropathy. Ital J Biochem 53:73-81.
44. McGinnis JF, Matsumoto B, Whelan JP, Cao W. 2002. Cytoskeleton participation in subcellular trafficking of signal transduction proteins in rod photoreceptor cells. J Neurosci Res 67:290-297.
45. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-1300.
46. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. 1999. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 163:374-379.
47. Nakazawa T, Takahashi H, Shimura M. 2006. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res 1093:141-149.
48. Narins CR, Lin DA, Burton PB, Jin ZG, Berk BC. 2004. Interleukin-18 and interleukin-18 binding protein levels before and after percutaneous coronary intervention in patients with and without recent myocardial infarction. Am J Cardiol 94:1285-1287.
49. Nicoletti F, Conget I, Di Marco R, Speciale AM, Morinigo R, Bendtzen K, Gomis R. 2001. Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44:309-311.
50. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Miyamoto K, Nishiwaki H, Mandai M, et al. 2000. Administration of 17β-estradiol attenuates retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 41:2689-2696.
51. Perry VH, Cowey A. 1984. Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey. Neuroscience 12:1125-1137.
52. Quigley HA. 1996. Number of people with glaucoma worldwide. Br J Ophthalmol 80:389-393.
53. Qureshi IA. 1996. Ocular hypertensive effect of menopause with and without systemic hypertension. Acta Obstet Gynecol Scand 75:266-269.
54. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. 2004. Global data on visual impairment in the year 2002. Bull World Health Organ 82:844-851.
55. Sator MO, Akramian J, Joura EA, Nessmann A, Wedrich A, Gruber D, Metka M, et al. 1998. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 29:93-95.
56. Sator MO, Joura EA, Frigo P, Kurz C, Metka M, Hommer A, Huber JC. 1997. Hormone replacement therapy and intraocular pressure. Maturitas 28:55-58.
57. Schuettauf F, Quinto K, Naskar R, Zurakowski D. 2002. Effects of anti-glaucoma medications on ganglion cell survival: The DBA/2J mouse model. Vision Res 42:2333-2337.
58. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, et al. 2000. Steroid synthesis and metabolism in the nervous system: Trophic and protective effects. J Neurocytol 29:307-326.
59. Sherwin BB. 1999. Progestogens used in menopause. Side effects, mood and quality of life. J Reprod Med 44:227-232.
60. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD. 1999. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188.
61. Szego EM, Barabas K, Balog J, Szilagyi N, Korach KS, Juhasz G, Abraham IM. 2006. Estrogen induces estrogen receptor α-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J Neurosci 26:4104-4110.
62. Vedder H, Anthes N, Stumm G, Wurz C, Behl C, Krieg JC. 1999. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 72:2531-2538.
63. Vidal-Sanz M, Villegas-Perez MP, Bray GM, Aguayo AJ. 1988. Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye diI. Exp Neurol 102:92-101.
64. Wise PM. 2002. Estrogens and neuroprotection. Trends Endocrinol Metab 13:229-230.
65. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y. 2001. Estrogens: Trophic and protective factors in the adult brain. Front Neuroendocrinol 22:33-66.
66. Wolfs RC, Borger PH, Ramrattan RS, Klaver CC, Hulsman CA, Hofman A, Vingerling JR, et al. 2000. Changing views on open-angle glaucoma: Definitions and prevalences - The Rotterdam Study. Invest Ophthalmol Vis Sci 41:3309-3321.
67. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, et al. 2004. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 β-estradiol-mediated neuroprotection. J Biol Chem 279:13086-13094.
68. Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. 2003. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 22:465-481.
69. Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, Maric D, Barker JL, et al. 2001. Estrogen protects against β-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12:1919-1923.
70. Zhou X, Li F, Kong L, Tomita H, Li C, Cao W. 2005. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J Biol Chem 280: 31240-31248.